Using NOD and Toll-Like Receptor 3 (TLR3) Knockout Mice in Type 1 Diabetes Research

16
Using NOD and Toll-Like Receptor 3 (TLR3) Knockout Mice in Type 1 Diabetes Research Tiffany Osemwengie

description

Using NOD and Toll-Like Receptor 3 (TLR3) Knockout Mice in Type 1 Diabetes Research. Tiffany Osemwengie. General Type-1 Diabetes Information. Type 1 diabetes mellitus is a chronic autoimmune disease that results in the destruction of the insulin-producing cells in the pancreas. - PowerPoint PPT Presentation

Transcript of Using NOD and Toll-Like Receptor 3 (TLR3) Knockout Mice in Type 1 Diabetes Research

Page 1: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Using NOD and Toll-Like Receptor 3 (TLR3) Knockout Mice in Type 1 Diabetes Research

Tiffany Osemwengie

Page 2: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

General Type-1 Diabetes Information

• Type 1 diabetes mellitus is a chronic autoimmune disease that results in the destruction of the insulin-producing cells in the pancreas.

• The insulin-producing cells are called beta cells• The disease often results in complete loss of

insulin production in the pancreas• Insulin is an essential hormone that is necessary

to allow glucose to enter cells to produce energy• Also known as insulin-dependent diabetes and

juvenile diabetes

Page 3: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Symptoms

• Increased thirst • Frequent

urination• Extreme hunger• Weight loss• Fatigue• Blurred vision

Page 4: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Complications of Type-1 Diabetes

• Cardiovascular Disease• Nerve damage (neuropathy)• Kidney damage • Eye damage (cataracts and blindness)• Foot damage• Skin and mouth conditions• Osteoporosis• Pregnancy complications• Hearing problems

Page 5: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Treatment• Fatal if left untreated • Insulin Injections• Exercising regularly and maintaining a healthy

weight• Eating healthy foods• Monitoring blood sugar

Page 6: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Type-1 Diabetes Research

Mouse pancreatic islet visualized using immunofluorescent microscopy

Page 7: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

NOD Mice• The non-obese diabetic (NOD) mouse• Widely used model of type-1 diabetes mellitus• NOD mice spontaneously develop autoimmune

insulin-dependent diabetes around the age of 15 weeks

• The strain was first developed at the Shionogi Research Laboratories in Aburahi, Japan by Makino and colleagues in 1980

• They were developed by selecting and inbreeding cataract-prone mice strains

Page 8: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

NOD Mice• The NOD mice were found to have a mutation in

exon 2 of the CTLA-4 gene• CTLA-4 plays an important role in regulating the

T-cell immune response• It is believed that the loss of function in the CTLA-

4 gene causes auto-reactive T-cells to attack insulin producing cells, which leads to the development of diabetes in the NOD mice

Page 9: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Toll-Like Receptors• Toll-like receptors (TLRs) are cellular sensors that

detect pathogens by recognizing specific pathogen-associated molecular patterns (PAMPs)

• Found on the surface of macrophages, dendritic cells, and NK cells

• Can also be found in the membranes of endosomes

• TLRs were also found to be expressed in human and rodent pancreatic islets

• Important role in innate immune responses• First line of defense against invading pathogens

Page 10: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Toll-like Receptors• There are 10 different expressed TLR genes in

humans, and 13 in mice• Each type of TLR recognizes a distinct set of

PAMPs• When a TLR recognizes a PAMP, a signaling

process occurs that leads to the production of cytokines and chemokines

Page 11: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Toll-like Receptors

Page 12: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Zeynep Dogusan et al. • It had been known previously that viral infections

could contribute to the pathogenesis of type-1 diabetes

• Viral products, especially double-stranded RNA (dsRNA), affected pancreatic β-cell survival and triggered autoimmunity

• The mechanism behind the induced β-cell death was unknown

• The researchers believed that it may have something to do with the TLR3 signaling pathway because TLR3 recognizes viral dsRNA

Page 13: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

TLR3 -/- Knockout Mutants• The gene for toll-like receptor 3 in mice is located

on chromosome 8• The gene was disrupted by targeted knockout

mutation• Exon 1 was replaced through homologous

recombination• Northern blot analysis detected a truncated

transcript in the knockout mutants• The mutant transcript does not encode a

functional protein

Page 14: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Zeynep Dogusan et al.• Wild-type and TLR3 -/- knockout mice were used

to determine if the TLR3 signaling pathway played a significant role in the development of the autoimmune condition.

• The pancreatic islets from the mice were isolated and incubated with PICex which is a synthetic dsRNA

• In another separate in-vivo study using NOD mice, the PICex synthetic dsRNA was shown to significantly accelerate the development of diabetes in the mice.

Page 15: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

Zeynep Dogusan et al.• The wild-type mice had a much higher

percentage of beta cell apoptosis than the TLR3 -/- knockout mice

• Indication that the detrimental effects of dsRNA on pancreatic β-cells were mediated by the TLR3 signaling pathway

• Suppression of the TLR3 signaling pathway protects β-cells against dsRNA-induced apoptosis

Page 16: Using NOD and Toll-Like Receptor  3 (TLR3)  Knockout Mice in Type 1 Diabetes Research

References• 1. Zeynep Dogusan, Mónica García, Daisy Flamez, Lena

Alexopoulou, Michel Goldman, Conny, Gysemans, Chantal Mathieu, Claude Libert, Decio L. Eizirik, and Joanne Rasschaert.Double-Stranded RNA Induces Pancreatic β-Cell Apoptosis by Activation of the Toll-Like Receptor 3 and Interferon Regulatory Factor 3 Pathways Diabetes 2008 57: 1236-1245.

• 2. Rasschaert J, Ladriere L, Urbain M, Dogusan Z, Katabua B, Sato S, Akira S, Gysemans C, Mathieu C, Eizirik, DL: Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-gamma-induced apoptosis in primary pancreatic beta-cells. J Biol Chem280 :33984 –33991,2005

• 3. Wen L, Peng J, Li Z, Wong, FS: The effect of innate immunity on autoimmune diabetes and the expression of toll-like receptors on pancreatic islets. Journal of Immunology 172 :3173 –3180,2004